Biblio

Export 3139 results:
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
M. Buongiorno, Antonelli, F., Compta, Y., Fernandez, Y., Pavía, J., Lomeña, F., Ríos, J., Ramírez, I., García, J. Ramón, Soler, M., Cámara, A., Fernández, M., Basora, M., Salazar, F., Sanchez-Etayo, G., Valldeoriola, F., Barrio, J. Raúl, and Marti, M. Jose, “Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1261-1272, 2017.
F. Jiménez-Altayó, Sánchez-Ventura, J., Vila, E., and Giménez-Llort, L., “Crosstalk between Peripheral Small Vessel Properties and Anxious-like Profiles: Sex, Genotype, and Interaction Effects in Mice with Normal Aging and 3×Tg-AD mice at Advanced Stages of Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1531-1538, 2018.
L. Iaccarino, Chiotis, K., Alongi, P., Almkvist, O., Wall, A., Cerami, C., Bettinardi, V., Gianolli, L., Nordberg, A., and Perani, D., “A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.”, J Alzheimers Dis, vol. 59, no. 2, pp. 603-614, 2017.
J. Raja Sundaram, Poore, C. Priscilla, Bin Sulaimee, N. Hazim, Pareek, T., Cheong, W. Fun, Wenk, M. R., Pant, H. C., Frautschy, S. A., Low, C. - M., and Kesavapany, S., “Curcumin Ameliorates Neuroinflammation, Neurodegeneration, and Memory Deficits in p25 Transgenic Mouse Model that Bears Hallmarks of Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1429-1442, 2017.
J. Subhash Rane, Bhaumik, P., and Panda, D., “Curcumin Inhibits Tau Aggregation and Disintegrates Preformed Tau Filaments in vitro.”, J Alzheimers Dis, vol. 60, no. 3, pp. 999-1014, 2017.
L. GjØra, Strand, B. Heine, Bergh, S., Borza, T., Brækhus, A., Engedal, K., Johannessen, A., Kvello-Alme, M., Krokstad, S., Livingston, G., Matthews, F. E., Myrstad, C., Skjellegrind, H., Thingstad, P., Aakhus, E., Aam, S., and Selbæk, G., “Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT Study.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1213-1226, 2021.
A. - M. Miller, Balasa, M., Blennow, K., Gardiner, M., Rutkowska, A., Scheltens, P., Teunissen, C. E., Visser, P. Jelle, Winblad, B., Waldemar, G., and Lawlor, B., “Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe.”, J Alzheimers Dis, vol. 60, no. 1, pp. 201-210, 2017.
M. Pacheco-Herrero, Soto-Rojas, L. O., Reyes-Sabater, H., Garcés-Ramirez, L., López, Fde la Cruz, Villanueva-Fierro, I., and Luna-Muñoz, J., “Current Status and Challenges of Stem Cell Treatment for Alzheimer's Disease.”, J Alzheimers Dis, vol. 84, no. 3, pp. 917-935, 2021.
C. L. Fisher, Resnick, R. J., De, S., Acevedo, L. A., Lu, K. Ping, Schroeder, F. C., and Nicholson, L. K., “Cyclic cis-Locked Phospho-Dipeptides Reduce Entry of AβPP into Amyloidogenic Processing Pathway.”, J Alzheimers Dis, vol. 55, no. 1, pp. 391-410, 2017.
J. Geng, Xia, L., Li, W., Zhao, C., and Dou, F., “Cycloheximide Treatment Causes a ZVAD-Sensitive Protease-Dependent Cleavage of Human Tau in Drosophila Cells.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1161-8, 2016.
E. Gauba, Guo, L., and Du, H., “Cyclophilin D Promotes Brain Mitochondrial F1FO ATP Synthase Dysfunction in Aging Mice.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1351-1362, 2017.
Y. - R. Wang, Wang, J., Liu, Y. - H., Hu, G. - L., Gao, C. - Y., Wang, Y. - J., Zhou, X. - F., and Zeng, F., “Cysteine-Rich Repeat Domains 2 and 4 are Amyloid-β Binding Domains of Neurotrophin Receptor p75NTR and Potential Targets to Block Amyloid-β Neurotoxicity.”, J Alzheimers Dis, vol. 63, no. 1, pp. 139-147, 2018.
A. Maes, Anthonissen, R., Wambacq, S., Simons, K., and Verschaeve, L., “The Cytome Assay as a Tool to Investigate the Possible Association Between Exposure to Extremely Low Frequency Magnetic Fields and an Increased Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 3, pp. 741-9, 2016.
D
A. Di Carlo, Baldereschi, M., Lamassa, M., Bovis, F., Inzitari, M., Solfrizzi, V., Panza, F., Galluzzo, L., Scafato, E., and Inzitari, D., “Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study.”, J Alzheimers Dis, vol. 53, no. 2, pp. 505-15, 2016.
V. R. Varma and Watts, A., “Daily Physical Activity Patterns During the Early Stage of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 659-667, 2017.
C. Overk and Masliah, E., “Dale Schenk One Year Anniversary: Fighting to Preserve the Memories.”, J Alzheimers Dis, vol. 62, no. 1, pp. 1-13, 2018.
L. Serra, Gabrielli, G. Bechi, Tuzzi, E., Spanò, B., Giulietti, G., Failoni, V., Marra, C., Caltagirone, C., Koch, G., Cercignani, M., and Bozzali, M., “Damage to the Frontal Aslant Tract Accounts for Visuo-Constructive Deficits in Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1015-1024, 2017.
R. A. A. de Heus, Reumers, S. F. I., van der Have, A., Tumelaire, M., Tully, P. J., and Claassen, J. A. H. R., “Day-to-Day Home Blood Pressure Variability is Associated with Cerebral Small Vessel Disease Burden in a Memory Clinic Population.”, J Alzheimers Dis, vol. 74, no. 2, pp. 463-472, 2020.
M. Nakanishi, Niimura, J., Yamasaki, S., and Nishida, A., “Death of Dementia Patients in Psychiatric Hospitals and Regional Supply of Psychiatric Services: Study of the National Data from 1996 to 2014 in Japan.”, J Alzheimers Dis, vol. 56, no. 2, pp. 817-824, 2017.
M. El Haj and Antoine, P., “Death Preparation and Boredom Reduction as Functions of Reminiscence in Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 2, pp. 515-23, 2016.
J. A. Matías-Guiu, Pytel, V., and Matías-Guiu, J., “Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia.”, J Alzheimers Dis, vol. 78, no. 2, pp. 537-541, 2020.
M. Waller, Buckley, R. F., Masters, C. L., Nona, F. R., Eades, S., and Dobson, A. J., “Deaths with Dementia in Indigenous and Non-Indigenous Australians: A Nationwide Study.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1589-1599, 2021.
L. Shi, Baird, A. L., Westwood, S., Hye, A., Dobson, R., Thambisetty, M., and Lovestone, S., “A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1181-1198, 2018.
C. Somers, Struyfs, H., Goossens, J., Niemantsverdriet, E., Luyckx, J., De Roeck, N., De Roeck, E., De Vil, B., Cras, P., Martin, J. - J., De Deyn, P. - P., Bjerke, M., and Engelborghs, S., “A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium.”, J Alzheimers Dis, vol. 54, no. 1, pp. 383-95, 2016.
E. Fuller-Thomson and Ahlin, K. Marie, “A Decade of Decline in Serious Cognitive Problems Among Older Americans: A Population-Based Study of 5.4 Million Respondents.”, J Alzheimers Dis, vol. 85, no. 1, pp. 141-151, 2021.

Pages